6 studies found for:    21969517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: nab-paclitaxel;   Drug: Cisplatin;   Drug: gemcitabine
2 Completed A Pilot Study of ODSH in Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: PGX-ODSH-2013-AML-1
3 Recruiting Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Untreated Pancreatic Adenocarcinoma;   Pancreatic Cancer Non-resectable;   Metastatic Pancreatic Adenocarcinoma;   Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations
Interventions: Drug: PLX7486-TsOH;   Drug: gemcitabine;   Drug: nab-Paclitaxel
4 Completed
Has Results
Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Albumin-bound paclitaxel
5 Recruiting Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: nab-paclitaxel;   Drug: FOLFIRINOX;   Genetic: Immunohistochemistry (IHC) Analysis;   Drug: Metformin;   Drug: mFOLFIRI
6 Unknown  Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Abraxane ( Nab-paclitaxel);   Drug: Gemcitabine;   Drug: ODSH ( 2-O, 3-O Desulfated Heparin);   Drug: Abraxane ( nab-paclitaxel)

Indicates status has not been verified in more than two years